Sort Results:
List of Partnerships
Janssen Pharmaceuticals and Johns Hopkins To Develop New Therapies to Treat Neurological Diseases |
|
Janssen Pharmaceuticals (Formerly OMJPI) a Johnson and Johnson entity has entered into collaboration agreement with Johns Hopkins Brain Science Institute ("BSi") at Johns Hopkins University.... |
Partner:
Janssen Pharmaceuticals |
JDRF & Novo Nordisk to Collaborate on Type 1 Diabetes |
|
JDRF and Novo Nordisk have entered into collaboration to develop new immunotherapies to treat Type 1 diabetes. The new partnership will be based out of Novo's newly opened Type 1 Diabetes R&D... |
Partner:
Novo Nordisk |
Johns Hopkins BSi Licenses GCPII Assets from Eisai |
|
Johns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds... |
Partner:
Eisai |
Johnson & Johnson to Support Pain Research at Queensland University |
|
Johnson & Johnson and Institute for Molecular Bioscience (IMB) at University of Queensland have entered into research agreement to develop peptides using IMB's novel assay to treat chronic... |
Partner:
Johnson & Johnson |
Merck Establishes New Center in San Diego with Academic Researchers |
|
Merck Pharmaceuticals has committed to fund $90 million over period of seven years to establish California Institute for Biomedical Research (Calibr) in San Diego, California. The new center will... |
Partner:
Merck |
Merck Serono and Feinstein Institute to Develop New Drugs to Treat Lupus |
|
Merck Serono and Feinstein Institute the research arm of North Shore-Long Island Jewish Health System in New York have entered into a joint collaboration to develop new antibody based therapies to... |
Partner:
Merck Serono |
Novartis and University of Pennsylvania form Alliance in Oncology Area |
|
University of Pennsylvania and Novartis have joined hands together to start a new Center for Advanced Cellular Therapies (CACT). The new center will be based out of University of Pennsylvania campus... |
Partner:
Novartis |
Novo Nordisk and Oxford to Develop Drugs to Treat Rheumatoid Arthritis and Other Inflammatory Diseases |
|
Novo Nordisk and Kennedy Institute of Rheumatology at Oxford University have entered into partnership to develop new drugs to treat Rheumatoid Arthritis and other inflammatory disorders. Novo... |
Partner:
Novo Nordisk |
Pfizer's CTI Establishes New Partnership with UCSF |
|
Pfizer's Center for Therapeutic Innovation has established a new multi-year research and development partnership with University of California, San Francisco (UCSF). Pfizer will provide $85 million... |
Partner:
Pfizer (Centers for Therapeutic Innovation) |
Pharma and Academia Consortium Partner to Develop New Drugs in Europe |
|
A consortium of academic institutes from Germany, Britain, Netherlands and Denmark partner with a group of leading pharmaceutical companies which include AstraZeneca, Sanofi, Bayer, UCB , ,... |
Partner:
AstraZeneca |